Universitaet Des Saarlandes — Clinical Trial Site

112 Registered trials

57 Currently recruiting

Organisation

Universitaet Des Saarlandes

Location

Homburg, Germany

Identifier

ORG-100031673

Address

Kirrberger Strasse, 66421, Germany

Departments

049005: Oncology
2606: Klinik fuer Innere Medizin I
276010
402: Klinik für Augenheilkunde
Clinic for Neurology
Clinic for Radiotherapy and Radiooncology
Clinic of Internal Medicine I
Department of Internal Medicine
Department of Internal Medicine I
Department of Internal Medicine I / Hematology, Oncology, Rheumatology and Clinical Immunology
Department of Medicine III
Department of Oncology, Haematology, Rheumatology and clinical Immunology
Department of Ophthalmology
Department of pneumology
Dermatology
Diagnostische & Interventionelle Radiologie
Director of the Department of Psychiatry and Psychotherapy
Division of Pediatric Endorcinology and Diabetes
Division of Pediatric Endorcinology and Diabetes
Dpt. of General Paediatrics and Neonatology
Dpt.of General Paediatrics and Neonatology
Frauenklinik
Gynecology and Obstetrics
Hematology/Oncology
Innere Medizin
Innere Medizin I
Innere Medizin V
Innere Medizin V – Pneumologie, Allergologie, Beatmungs- und Umweltmedizin
Innere Medizin V – Pneumologie, Allergologie, Beatmungs- und Umweltmedizin
Innere Medizin V Lungenkrebszentrum
Innere Medizin V, IMED
Innere Medizin, Hämatologie und Onkologie
Institut für Innere Medizin I
Institut für Klinische Hämostaseologie und Transfusionsmedizin
Institut für Medizinische Mikrobiologie und Hygiene
Int. Medicine and Pneumology
Internal Medicine
Internal Medicine III
Klinik fuer Psychiatrie und Psychotherapie
Klinik für Augenheilkunde
Klinik für Dermatologie, Venerologie und Allergologie
Klinik für Frauenheilkunde
Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin
Klinik für Gynäkologie, Geburtshilfe und Reproduktionsmedizi
Klinik für Innere Medizin I
Klinik für Innere Medizin I Hämatologie & Onkologie & KMT
Klinik für Innere Medizin I, Gebäude 41
Klinik für Innere Medizin II
Klinik für Innere Medizin II, Haematologie/Onkologie
Klinik für Innere Medizin III Kardiologie, Angiologie und Internistische Intensivmedizin
Klinik für Innere Medizin V
Klinik für Innere Medizin V IMED Gebäude
Klinik für Innere Medizin V- Pneumologie, Allergologie, Beatmungs- und Umweltmedizin
Klinik für Neurologie
Klinik für Pädiatrische Onkologie und Hämatologie
Klinik für Psychiatrie und Psychotherapie
Klinik für Strahlentherapie und Radioonkologie
Klinik für Urologie und Kinderurologie
Klinik IMED 41.1
Klinisches Studienzentrum der Innere Medizin III
Lungenkrebszentrum
N/A
NA
not applicable
Oncology, Haematology, Rheumatology and clinical Immunology
Onkologie, Hämatologie, Rheumatologie und klinische Immunologie
Pädiatrische Onkologie und Hämatologie
Psychiatry
UKS-Universitätsklinikum des Saarlandes Klinik für Innere Medizin II
Universitätsklinikum des Saarlandes Klinik für Augenheilkunde
Universitätsklinikum des Saarlandes, Klinik für Augenheilkunde
Urology

Clinical trials at this site (112)

Search interface

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Not authorised

2023-509861-19-00 Diffuse large B-cell lymphoma (DLBCL) 4
A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending

2024-514246-37-00 Idiopathic pulmonary fibrosis (IPF) 4
Durvalumab (MEDI4736) in combination with consolidative radiochemotherapy and ablative stereotactic radiotherapy in extensive stage SCLC Pending

2024-517937-41-00 extensive stage small cell lung cancer (SCLC) 4
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending

2025-521113-13-00 Early Parkinson’s Disease 10
A Long-term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Hypertension Associated with In… Pending

2025-521769-29-00 Pulmonary Hypertension Associated with Interstitial Lun 5
A Phase 1 Study of AIR-001 in Adults with AATD. Pending

2025-523558-14-00 Alpha-1 Antitrypsin Deficiency 1
A trial to learn how safe newer immunotherapy drugs are and how well they work with or without other anti-cancer drugs in adults with advanc… Pending

2025-523599-21-00 Non-small Cell Lung Cancer 4
A clinical study to investigate the safety and tolerability of efimosfermin alfa injection in participants with known or suspected F2- or F3… Pending

2025-523674-16-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A pivotal clinical study to investigate the safety and efficacy of efimosfermin alfa injection in participants with biopsyconfirmed F2- or F… Pending

2025-523675-39-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5
A multicenter, randomized, double-blind, placebo-controlled, adaptive, non-inferiority trial to investigate shortening treatment duration in… Pending

2026-525640-14-00 Candidemia 6
An efficacy and safety study of cenegermin ophthalmic solution compared with vehicle in the treatment of PCED Recruiting

2025-523443-35-00 Persistent Corneal Epithelial Defect (PCED) 5 2026-06-11
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), compared with Topotecan in… Recruiting

2025-521627-78-00 Neoplasms, Lung 5 2026-01-28
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
An Efficacy and Safety Study of Trontinemab in Participants With Early Symptomatic Alzheimer’s Disease (MCI to Mild Dementia Due to AD) Recruiting

2024-518006-40-00 Early Symptomatic Alzheimer’s Disease (MCI to Mild Deme 5 2025-11-13
An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy versus Treatment of Physician’s Choice in Hormone Rec… Recruiting

2025-520582-51-00 Hormone receptor positive breast cancer 5 2025-10-17
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
AFFIRM: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Pri… Recruiting

2024-516525-31-01 Primary Biliary Cholangitis 5 2025-07-14
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
AZD5305 vs Placebo in Men with Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents. Recruiting

2023-504214-30-00 Metastatic Castration-Sensitive Prostate Cancer (mCSPC) 5 2024-06-27
A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-c… Recruiting

2023-507402-13-00 Multiple myeloma 5 2024-04-03
PREFer Recruiting

2024-520138-31-00 Early-stage favorable classic Hodgkin lymphoma 4 2026-06-01
A study to test the effects and safety of palopegteriparatide in adolescents with long-term hypoparathyroidism Recruiting

2025-523928-52-00 Chronic hypoparathyroidism 5 2026-04-22